| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 524 | 1.708 | 6.335 | 6.624 | 3.785 | 15.169 | 21.616 | 17.162 | 50.758 | 19.090 |
| Total Income - EUR | 524 | 3.796 | 7.549 | 10.189 | 16.556 | 24.002 | 24.766 | 21.830 | 54.698 | 96.532 |
| Total Expenses - EUR | 58 | 3.208 | 6.874 | 9.692 | 14.477 | 23.670 | 16.332 | 15.685 | 41.624 | 95.916 |
| Gross Profit/Loss - EUR | 466 | 587 | 675 | 497 | 2.079 | 332 | 8.434 | 6.145 | 13.074 | 617 |
| Net Profit/Loss - EUR | 450 | 536 | 537 | 431 | 2.041 | 181 | 7.784 | 5.739 | 12.864 | 540 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Bio Mironesti Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 114 | 4.194 | 24.859 | 40.998 | 38.101 | 41.038 | 35.896 | 34.004 | 42.612 | 37.940 |
| Current Assets | 610 | 1.072 | 9.400 | 4.465 | 8.348 | 11.927 | 17.016 | 17.432 | 116.129 | 53.797 |
| Inventories | 0 | 262 | 2.746 | 3.873 | 5.029 | 8.887 | 85 | 542 | 289 | 3.624 |
| Receivables | 524 | 802 | 263 | 0 | 63 | 2.616 | 12.294 | 14.144 | 100.622 | 27.955 |
| Cash | 85 | 8 | 6.392 | 592 | 3.256 | 423 | 4.638 | 2.746 | 15.218 | 22.219 |
| Shareholders Funds | 562 | 1.093 | 1.611 | 2.012 | 4.014 | 4.119 | 11.811 | 13.657 | 26.480 | 26.872 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 161 | 4.173 | 2.839 | 15.669 | 9.713 | 20.447 | 17.657 | 17.894 | 23.186 | 32.888 |
| Income in Advance | 0 | 0 | 29.809 | 27.782 | 32.722 | 28.400 | 24.150 | 20.595 | 109.986 | 32.383 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "124 - 124" | |||||||||
| CAEN Financial Year |
124
|
|||||||||
Comments - Bio Mironesti Srl